@acr-journals.bsky.social :
using #EUSTAR database of Systemic Sclerosis patients,
we emulate a trial: does Oral glucocorticoids in addition to immunosuppression improve skin fibrosis ?
Answer: likely no ⬇️🧵
acrjournals.onlinelibrary.wiley.com/doi/10.1002/...
#MedSky #Rheumatology
@acr-journals.bsky.social :
using #EUSTAR database of Systemic Sclerosis patients,
we emulate a trial: does Oral glucocorticoids in addition to immunosuppression improve skin fibrosis ?
Answer: likely no ⬇️🧵
acrjournals.onlinelibrary.wiley.com/doi/10.1002/...
#MedSky #Rheumatology
Now that I've returned from the #ACR24 meeting, I have the time to review talks! One of my favorites is one on Genetically Transitional Disease by Drs. Aksentijevich and Milner.
Now that I've returned from the #ACR24 meeting, I have the time to review talks! One of my favorites is one on Genetically Transitional Disease by Drs. Aksentijevich and Milner.
• By Dr. Maria Dall'Era (UCSF)
Review of #LupusNephritis 🫘
▪️Rx TRIPLE therapy
▪️belimumab vs voclosporin
▪️low level proteinuria (even *UPCR <0.5*) can STILL be associated with disease activity (Class III/IV/V)
#Lupus #RheumSky #NephSky
• By Dr. Maria Dall'Era (UCSF)
Review of #LupusNephritis 🫘
▪️Rx TRIPLE therapy
▪️belimumab vs voclosporin
▪️low level proteinuria (even *UPCR <0.5*) can STILL be associated with disease activity (Class III/IV/V)
#Lupus #RheumSky #NephSky
Presented by Dr. Michael Pillinger
• Review some of the most impactful studies in Rheumatology from the past year!
#MedSky #Rheumatology #RheumSky
Presented by Dr. Michael Pillinger
• Review some of the most impactful studies in Rheumatology from the past year!
#MedSky #Rheumatology #RheumSky